RAD50 haploinsufficiency observed in T-lymphocytes of Finnish breast cancer patients carrying heterozygous LOF mutations such as the Finnish founder mutation RAD50 687delT resulted in increased genomic instability [26]. Here, RAD50 is linked to breast cancer.